ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,632Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 26

$719K Total Retail Price of All Prescriptions

Rank: 4 out of 26

448 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 5,530 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$94 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SYNTHROID 437 310 1 1
GLIMEPIRIDE 411 332 2 3
LEVOTHYROXINE SODIUM 369 278 3 2
SIMVASTATIN 356 301 4 5
METFORMIN HCL 250 209 5 4
CRESTOR 236 161 6 9
CARVEDILOL 231 179 7 19
LISINOPRIL 196 147 8 6
PRAVASTATIN SODIUM 179 143 9 8
LANTUS 174 115 10 7
FENOFIBRATE 173 144 11 32
METFORMIN HCL ER 169 113 12 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 156 128 13 23
GABAPENTIN 152 113 14 27
ATORVASTATIN CALCIUM 145 118 15 11
HYDROCHLOROTHIAZIDE 106 87 16 24
AMLODIPINE BESYLATE 98 72 17 10
CITALOPRAM HBR 92 60 18 80
NOVOLOG 92 46 18 16
HUMALOG 90 58 20 20
LOSARTAN POTASSIUM 87 64 21 26
ZOLPIDEM TARTRATE 86 58 22 45
LANTUS SOLOSTAR 86 58 22 14
HUMULIN N 85 70 24 34
JANUMET 80 64 25 33
METHIMAZOLE 78 63 26 18
INSULIN SYRINGE 77 53 27 15
AMLODIPINE BESYLATE-BENAZEPRIL 76 41 28 66
LEVEMIR 69 33 29 68
ALENDRONATE SODIUM 69 67 29 28
LOVAZA 67 35 31 55
HUMULIN R 65 0 32 31
FUROSEMIDE 64 31 33 24
RAMIPRIL 62 44 34 40
LYRICA 60 23 35 57
OMEPRAZOLE 60 47 35 29
PLAVIX 59 48 37 93
CLOPIDOGREL 59 37 37 69
DIOVAN 59 39 37 38
PEN NEEDLE 58 36 40 13
VYTORIN 53 38 41 72
LEVEMIR FLEXPEN 53 42 41 30
NOVOLIN 70-30 50 27 43 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.